Dr Taub and Dr Patel discuss how to assess for cardiovascular risk in your patients.
Back
Expanding Horizons on Who can Benefit from Non-Statin LDL-Cholesterol Lowering Therapy for Cardiovascular Risk Reduction
Expert cardiologists discuss the role of non-statin therapies in lowering LDL cholesterol, recent clinic trial data on who can benefit, as well as how to implement these agents into your clinical practice.
Expanding Horizons on Who can Benefit from Non-Statin LDL-Cholesterol Lowering Therapy for Cardiovascular Risk Reduction
Episodes
All
All
Dr Taub discusses how to match the intensity of lipid lowering therapy to the assessed cardiovascular risk.
Expert cardiologists discuss if there is such a thing as an LDL that is a too low.
Dr Taub and Dr Patel discuss which non statin agents are available for LDL-C lowering.
Expert cardiologists describe the importance of combination therapy for hyperlipidemia in high risk patients
Dr Taub describes effective strategies in overcoming access barriers to novel lipid lowering therapies.
Expert cardiologists discuss the cumulative burden of an elevated cholesterol over time.
Dr Kohli gives an overview of the mechanisms of action of non-statin agents for the management of hyperlipidemia.
Expert cardiologists discuss the recent clinical trials results of the CLEAR-OUTCOMES trial and thee sub analysis on the inflammatory marker hcCRP.
Cardiologists discuss how to select the right treatment for your patient with hyperlipidemia
Dr Taub, Dr Patel, and Dr Kohli look ahead to the future of the management of cardiovascular risk and hyperlipidemia
Advertisement
Advertisement
Trending on HCPLive
1
Alpha-Gal Syndrome: Closing an Underrecognized Allergy Diagnostic Gap
2
GRI-0621 Improves FVC, Reduces Fibrotic Biomarkers in IPF
3
ORFAN-MAESTRIA: AI Predicts Cardioembolic Stroke, Atrial Fibrillation from CT Scans
4
Pelacarsen Misses Primary Endpoint in Lp(a)HORIZON Phase 3 Trial
5